EFNB2 and myocardial infarction: Moreover, VEGFR3 inhibitor MAZ51 significantly diminished the EphrinB2-mediated lymphangiogenesis and impaired the heart repair post-MI, further confirming that cardiac lymphangiogenesis has an impact on myocardial remodeling and dysfunction.